May 30 (Reuters) - CSL Ltd (CSL) :
- CSL SEQIRUS TO COMPLETE FILL, FINISH PROCESS FOR PRE-PANDEMIC VACCINE TO SUPPORT U.S. GOVERNMENT'S OUTBREAK & PREPAREDNESS RESPONSE
- UNDER TERMS OF AGREEMENT, CSL SEQIRUS WILL DELIVER 4.8 MILLION DOSES OF PRE-PANDEMIC VACCINE
- 4TH AVIAN INFLUENZA PANDEMIC PREPAREDNESS AWARD TO CSL SEQIRUS UNDER MULTI-YEAR AGREEMENT WITH BIOMEDICAL ADVANCED RESEARCH & DEVELOPMENT AUTHORITY
(([email protected];))
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$263.95 |
Change
8.640(3.38%) |
Mkt cap ! $127.8B | |||
| Open | High | Low | Value | Volume |
| $258.12 | $264.81 | $257.91 | $311.0M | 1.182M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 833 | $263.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $263.98 | 30529 | 2 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |